| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2183056 | Immunobiology | 2013 | 8 Pages |
Abstract
These data demonstrate successful tolerization towards Bet v 1 by molecular chimerism. Stable long-term chimerism was achieved under inhibition of CD26. These results provide evidence for the broad applicability of molecular chimerism as tolerance strategy in allergy.
Keywords
5-FUFCMLTRVSVTMDmAbRBLBMTBMCHSCEAEAllergyexperimental autoimmune encephalomyelitisToleranceLong terminal repeatstandard errorstandard error of the meantransmembrane domainSignal sequencehematopoietic stem cellsBone marrow cellsFlow cytometryMHCmajor histocompatibility complexSEMVesicular stomatitis virusMonoclonal antibodiesBone marrow transplantation
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Martina Gattringer, Ulrike Baranyi, Nina Pilat, Karin Hock, Christoph Klaus, Elisabeth Buchberger, Haley Ramsey, John Iacomini, Rudolf Valenta, Thomas Wekerle,